UBS Group’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
475,047
+226,617
| +91% | +$134K | ﹤0.01% | 5268 |
|
|
2025
Q1 | $218K | Sell |
248,430
-9,789
| -4% | -$8.58K | ﹤0.01% | 5254 |
|
|
2024
Q4 | $436K | Buy |
258,219
+207,140
| +406% | +$350K | ﹤0.01% | 4787 |
|
|
2024
Q3 | $98.1K | Buy |
51,079
+26,274
| +106% | +$50.4K | ﹤0.01% | 5200 |
|
|
2024
Q2 | $61K | Sell |
24,805
-26,208
| -51% | -$64.5K | ﹤0.01% | 5394 |
|
|
2024
Q1 | $83.7K | Buy |
51,013
+2,694
| +6% | +$4.42K | ﹤0.01% | 5145 |
|
|
2023
Q4 | $86K | Buy |
48,319
+12,067
| +33% | +$21.5K | ﹤0.01% | 5066 |
|
|
2023
Q3 | $166K | Sell |
36,252
-4,345
| -11% | -$19.9K | ﹤0.01% | 4388 |
|
|
2023
Q2 | $454K | Buy |
40,597
+35,388
| +679% | +$396K | ﹤0.01% | 3897 |
|
|
2023
Q1 | $59K | Buy |
5,209
+2,571
| +97% | +$29.1K | ﹤0.01% | 5245 |
|
|
2022
Q4 | $18.1K | Buy |
2,638
+1,845
| +233% | +$12.7K | ﹤0.01% | 6587 |
|
|
2022
Q3 | $7K | Sell |
793
-713
| -47% | -$6.29K | ﹤0.01% | 7790 |
|
|
2022
Q2 | $15K | Buy |
+1,506
| New | +$15K | ﹤0.01% | 6272 |
|
|
2022
Q1 | – | Sell |
-755
| Closed | -$7K | – | 9508 |
|
|
2021
Q4 | $7K | Buy |
+755
| New | +$7K | ﹤0.01% | 8037 |
|